Blog - QualityStocks

ThursdaySep 17, 2026 11:58 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Forms TechForce Advanced Manufacturing to Pursue Semiconductor Equipment Partnership

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced the formation of TechForce Advanced Manufacturing Inc., a Nevada corporation established to pursue an advanced-manufacturing partnership with JUN LONG MACHINE INDUSTRIAL CO., LTD. The planned venture is intended to be owned 51% by Nightfood and 49% by JUN LONG, with the parties anticipating a definitive agreement within the next several weeks. TechForce Advanced Manufacturing plans to expand production of an automated Wafer Sorter and Automated Optical Inspection ("AOI") system for 8-inch and 12-inch silicon wafers. JUN LONG currently holds customer purchase orders that the venture expects to begin fulfilling following completion of the definitive agreement, supporting a target of beginning production and generating…

ThursdaySep 17, 2026 11:40 am

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Host Webinar on Open-Medicine AI Platform, Business Model and Development Roadmap

Lantern Pharma (NASDAQ: LTRN), a clinical-stage, AI-native biopharma company using artificial intelligence and genomic data to develop precision oncology therapies, announced it will host a live webinar Sept. 23 at 12:30 p.m. Eastern to present the business model, development roadmap and value proposition of Open-Medicine AI ("OMAI"), its wholly owned subsidiary developing a multi-agentic AI platform for end-to-end therapeutic development. The session, led by Panna Sharma, founder and CEO of Open-Medicine AI, will cover OMAI platform architecture, expansion beyond rare cancers into additional disease categories and therapeutic modalities and its planned subscription and enterprise licensing business model. To view the full press release, visit https://ibn.fm/gGQBc…

ThursdaySep 17, 2026 11:31 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price Target

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM), a biopharmaceutical company developing treatments for neurodegenerative and metabolic disorders and alcohol misuse disorders, announced that Rodman & Renshaw initiated coverage of the company with a Buy rating and a $8 price target. The research report was led by Michael G. King Jr., director of research and senior biotechnology analyst at Rodman & Renshaw. Quantum BioPharma said the coverage is unpaid and that it provided no consideration or fees for the report. To view the full press release, visit https://ibn.fm/OC9TG About Quantum BioPharma Ltd. Quantum is a biopharmaceutical company dedicated to building a…

ThursdaySep 17, 2026 11:20 am

QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Joins €6.3 Million French Government-Funded DETECSEPS Sepsis Project

VolitionRx Limited (NYSE American: VNRX) announced the official launch of the DETECSEPS project for the early detection of sepsis as part of the DETECSEPS Consortium, which is receiving €6.3 million, or approximately $7.3 million, in French government funding. The project is an initiative of IHU SEPSIS, coordinated and sponsored by Assistance Publique - Hôpitaux de Paris in partnership with Hospices Civils de Lyon, IDS France and Volition. Volition will provide the project’s sole biomarker, Nu.Q NETs, while IDS France will provide its automated analyzer to measure the biomarker. DETECSEPS will evaluate an early detection approach combining a routinely used clinical score with Volition’s Nu.Q NETs H3.1 blood…

ThursdaySep 17, 2026 10:55 am

QualityStocksNewsBreaks – Silynxcom Ltd. (NYSE American: SYNX) Receives Two Consecutive Orders Totaling Approximately $400,000 for CLARUS In-Ear Headset Systems

Silynxcom (NYSE American: SYNX), a manufacturer and developer of ruggedized tactical communication headset devices and other communication accessories, announced it has received two consecutive purchase orders totaling approximately $400,000 from a leading global defense company for its CLARUS In-Ear Headset system family of products. The systems are designated for a European army, with Silynxcom saying the orders represent a further step in its expanding presence across European markets. To view the full press release, visit https://ibn.fm/AA79G About Silynxcom Ltd. Silynxcom develops, manufactures and sells ruggedized tactical protective and communication headset devices, along with related communication accessories, that have been field-tested…

ThursdaySep 17, 2026 9:30 am

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured in AINewsWire Editorial on GPS-Denied Drone Navigation

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced its placement in an AINewsWire editorial examining the growing need for navigation technology in GPS-denied environments. The editorial highlights SPARC AI Overwatch Positioning Network, which moves positioning off the aircraft by using existing drone telemetry to return latitude, longitude and time in under a second without additional onboard hardware, positioning the technology as a software-defined, per-device subscription model for drone fleets. To view the full press release, visit https://ibn.fm/U1SpZ About SPARC AI Inc. SPARC AI is…

ThursdaySep 17, 2026 9:10 am

QualityStocksNewsBreaks – Streamex Corp. (NASDAQ: STEX) Announces Sixth GLDY Yield Distribution

Streamex (NASDAQ: STEX), a technology company focused on commodity-market tokenization, announced that the sixth yield payment for GLDY, its yield-bearing gold asset, will be distributed Sept. 17, 2026, covering Aug. 1 through Aug. 31. The company said GLDY currently earns a targeted annualized yield of 3.5% through its institutional gold leasing program. For August, 10.617518 GLDY, representing 10.617518 ounces of gold, will be distributed, resulting in a distribution of 0.003347 ounce of GLDY per token. To view the full press release, visit https://ibn.fm/1Y0Lt About Streamex Corp. Streamex Corp. (NASDAQ: STEX) is a technology and infrastructure company focused on the tokenization…

ThursdaySep 17, 2026 9:00 am

QualityStocksNewsBreaks – Earth Science Tech, Inc. (OTCQB : ETST) Uplists to OTCQB Venture Market

Earth Science Tech (OTCQB : ETST), a holding company with a diversified portfolio of distinct entities, announced its successful uplisting to the OTCQB Venture Market, effective for trading Sept. 17, 2026. The OTCQB requires companies to meet financial and reporting standards, undergo annual verification and comply with management certification requirements. To view the full press release, visit https://ibn.fm/oYq2M About Earth Science Tech, Inc. (ETST) Earth Science Tech, Inc. operates as a diversified holding company focused on the health and wellness sector. The Company’s principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine…

WednesdaySep 16, 2026 3:56 pm

QualityStocksNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Centers Digital-Asset Strategy on MindChain and NILA

MindWave Innovations (NYSE American: APUS) is concentrating its blockchain strategy around an interconnected ecosystem consisting of MindChain, the native NILA token, MindWaveDAO, and specialized Subnets. At the core is MindChain, an Ethereum-compatible Layer 2 that the company is developing as the infrastructure for the broader platform, with NILA intended to serve as its native asset and MindWaveDAO providing a decentralized governance and community layer. The company’s Subnet architecture is designed to support specialized applications, including environmental asset tokenization through ALCI, institutional real-estate infrastructure through Nexus Global Partners, and blockchain-based insurance through BlockAssure. Rather than treating these projects as separate digital-asset…

WednesdaySep 16, 2026 3:40 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Developing Next-Gen Cancer Therapies with Dual-Targeting Approach

VERAXA Biotech (NASDAQ: VRXA) is developing an oncology pipeline centered on engineered antibody therapies, with a particular focus on bispecific antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”). Its proprietary BiTAC platform uses a dual-targeting “AND-gated” approach intended to activate therapeutic effects preferentially when two tumor-associated targets are present on the same cancer cell, potentially addressing the challenge of on-target, off-tumor toxicity. The company has reported early laboratory data supporting the concept in both TCE and ADC applications, while its lead BiTAC-TCE has advanced into cell-line development and planned IND/CTA-enabling work following regulatory feedback from Germany’s Paul-Ehrlich-Institute. Separately, VERAXA’s VXA-222 bispecific…

Site Search

Company Search